Patent Assignment
Reel/Frame 031288/0530
Security Agreement
Recorded: 2013-09-17
Pages: 34
Assignor
WELLSTAT BIOLOGICS CORPORATION
Executed: 2013-08-20
Assignee
PDL BIOPHARMA, INC.
932 SOUTHWOOD BOULEVARD, INCLINE VILLAGE, NEVADA, 89451
Covered Properties
(63)
Oncolytic Virus
Patent:
8,147,822 →
Application:
09/664,444 →
Oncolytic virus
Application:
10/743,639 →
Publication:
US 2004/0208849
Oncolytic virus
Application:
10/743,649 →
Publication:
US 2004/0170607
Oncolytic Virus
Application:
11/685,483 →
Publication:
US 2007/0166287
Oncolytic Virus
Application:
60/287,590 →
Treatment of Neoplasms with Viruses
Application:
08/948,244 →
Treatment of neoplasms with viruses
Application:
10/044,955 →
Publication:
US 2003/0044384
Treatment of Neoplasms with Viruses
Application:
09/168,883 →
Treatment of Neoplasms with Viruses
Purging of cells using viruses
Application:
09/888,626 →
Publication:
US 2002/0037543
Purging of Cells Using Viruses
Purging of Cells Using Viruses
Application:
11/671,498 →
Publication:
US 2007/0141033
Purging of cells using viruses
Application:
60/214,014 →
Oncolytic virus
Application:
60/250,131 →
Oncolytic virus
Application:
60/327,016 →
Immunogenic Agent Therapy Using Plasmapheresis
Application:
11/677,853 →
Publication:
US 2007/0258991
Immunogenic agent therapy using plasmapheresis
Application:
60/375,931 →
Immunogenic agent therapy using exchange transfusion
Application:
10/512,760 →
Publication:
US 2005/0169889
Treatment of Neoplasms with Viruses
Application:
09/292,376 →
Treatment of Neoplasms with Rna Viruses
Infection and Treatment of Neoplasms with Vesicular Stomatitis Virus
Treating carcinoid neoplasms with therapeutic viruses
Application:
10/700,143 →
Publication:
US 2004/0131595
Treating carcinoid neoplasms with therapeutic viruses
Application:
60/423,952 →
Treating carcinoid neoplasms with therapeutic viruses
Application:
60/457,034 →
Treating hepatocellular carcinomas using therapeutic viruses
Application:
60/465,622 →
Treating hepatocellular carcinomas using therapeutic viruses
Application:
10/554,337 →
Publication:
US 2006/0204476
Newcastle disease virus administration
Application:
60/457,078 →
Newcastle disease virus administration
Application:
10/548,057 →
Publication:
US 2007/0077559
Anti-cancer virus desensitization method
Application:
60/457,035 →
Anti-cancer virus desensitization method
Application:
10/547,654 →
Publication:
US 2006/0099189
Cancer treatment using viruses and camptothecins
Application:
60/565,631 →
Cancer Treatment Using Viruses and Camptothecins
Application:
11/568,228 →
Publication:
US 2007/0207149
Mutant Viruses and Uses Thereof
Mutant Vesicular Stomatitis Viruses and Uses Thereof
Detection of Elevated Levels of Her-2/Neu Protein on Circulating Cancer Cells and Treatment
Application:
12/708,159 →
Publication:
US 2011/0070598
Detection of elevated levels of Her-2/neu protein on circulating cancer cells and treatment
Application:
60/616,332 →
Detection of Elevated Levels of Her-2/Neu Protein on Circulating Cancer Cells and Treatment
Application:
11/575,811 →
Publication:
US 2008/0261243
Stable and Filterable Enveloped Virus Formulations
Cancer Treatment Using Viruses, Fluoropyrimidines and Camptothecins
Application:
12/839,829 →
Publication:
US 2011/0117060
Cancer treatment using viruses, fluoropyrimidines and camptothecins
Application:
60/699,195 →
Cancer Treatment Using Viruses, Fluoropyrimidines and Camptothecins
Detection of Steroid Receptors on Circulating Carcinoma Cells and Treatment
Application:
60/745,012 →
Detection of Steroid Receptors on Circulating Carcinoma Cells and Treatment
Application:
12/296,458 →
Publication:
US 2009/0291920
Detection of Circulating Endothelial Cells
Application:
60/745,014 →
Detection of Circulating Endothelial Cells
Detection of Proteins from Circulating Neoplastic Cells
Application:
60/745,016 →
Detection of Proteins from Circulating Neoplastic Cells
Use of a Combination of Myxoma Virus and Rapamycin for Therapeutic Treatment
Application:
12/850,599 →
Publication:
US 2011/0195050
Use of a Combination of Myxoma Virus and Rapamycin for Therapeutic Treatment
Application:
13/679,096 →
Publication:
US 2013/0171106
Use of a Combination of Myxoma Virus and Rapamycin for Therapeutic Treatment
Application:
11/908,076 →
Publication:
US 2009/0035276
Detection of Elevated Levels of Her-2/Neu Protein from Non-Isolated Circulating Cancer Cells and Treatment
Application:
60/912,833 →
Detection of Elevated Levels of Her-2/Neu Protein from Non-Isolated Circulating Cancer Cells and Treatment
Application:
12/593,160 →
Publication:
US 2010/0120072
Histidine for Stable Aqueous Storage of Enveloped Viruses
Application:
61/577,168 →
Stable Storage Enveloped Viruses in Histidine Aqueous Solution
Application:
61/579,685 →
Oncolytic Virus Therapy
Oncolytic Virus Therapy
Oncolytic virus therapy
Application:
60/290,051 →
Administration of Therapeutic Viruses
Application:
12/409,711 →
Publication:
US 2009/0180993
Administration of therapeutic viruses
Application:
60/390,632 →
Administration of therapeutic viruses
Application:
10/518,732 →
Publication:
US 2005/0220818
Methods of Treating and Detecting Cancer Using Viruses
Patent:
7,056,689 →
Application:
08/260,536 →
Methods of Treating and Detecting Cancer Using Viruses
Oncolytic Virus Therapy
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 29, 1997
From: ROBERTS, MICHAEL S.; LORENCE, ROBERT M.; GROENE, WILLIAM S.; RABIN, HARVEY
To: PRO-VIRUS, INC.
Reel/Frame 008873/0298 →
Assignment of Assignor's Interest
Dec 23, 1998
From: ROBERTS, MICHAEL S.; LORENCE, ROBERT M.; GROENE, WILLIAM S.; RABIN, HARVEY
To: PRO-VIRUS, INC.
Reel/Frame 009674/0188 →
Assignment of Assignor's Interest
Jun 16, 1999
From: ROBERTS, MICHAEL S.; LORENCE, ROBERT M.; GROENE, WILLIAM S.; RABIN, HARVEY
To: PRO-VIRUS, INC.
Reel/Frame 010030/0167 →
Assignment of Assignor's Interest
Nov 15, 2001
From: HEILMAN, CONRAD J. JR.; LORENCE, ROBERT M.; ROBERTS, MICHAEL S.
To: PRO-VIRUS
Reel/Frame 012308/0108 →
Assignment of Assignor's Interest
Jan 16, 2002
From: BROWN, EARL GARNET; MBISA, JEAN LUTAMYO; BELL, JOHN CAMERON; STOJDL, DAVID FRANCIS
To: OTTAWA, UNIVERSITY OF
Reel/Frame 012486/0114 →
Assignment of Assignor's Interest
Jan 16, 2002
From: BROWN, EARL GARNET; MBISA, JEAN LUTAMYO; BELL, JOHN CAMEREON; STOJDL, DAVID FRANCIS
To: UNIVERSITY OF OTTAWA
Reel/Frame 012486/0088 →
Assignment of Assignor's Interest
Jan 16, 2002
From: UNIVERSITY OF OTTAWA, THE
To: PRO-VIRUS, INC.
Reel/Frame 012486/0061 →
Assignment of Assignor's Interest
Jan 16, 2002
From: THE UNIVERSITY OF OTTAWA
To: PRO-VIRUS, INC.
Reel/Frame 012486/0042 →
Assignment of Assignor's Interest
Feb 25, 2002
From: BROWN, EARL GARNET; MBISA, JEAN LUTAMYO; BELL, JOHN CAMERON; STOJDL, DAVID FRANCIS
To: OTTAWA, UNIVERSITY OF
Reel/Frame 012612/0461 →
Assignment of Assignor's Interest
Mar 12, 2002
From: OTTAWA, UNIVERSITY OF
To: PRO-VIRUS, INC.
Reel/Frame 012669/0031 →
Assignment of Assignor's Interest
Mar 12, 2002
From: SONENBERG, NAHUM
To: OTTAWA, UNIVERSITY OF
Reel/Frame 012669/0037 →
Assignment of Assignor's Interest
Mar 12, 2002
From: BELL, JOHN C.; STOJDL, DAVID F.; BROWN, EARL G.; ATKINS, HAROLD L.
To: OTTAWA, UNIVERSITY OF
Reel/Frame 012669/0053 →
Assignment of Assignor's Interest
Mar 26, 2002
From: ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING (MCGILL UNIVERSITY), THE
To: SONENBERG, NAHUM
Reel/Frame 012719/0924 →
Assignment of Assignor's Interest
Apr 26, 2002
From: LORENCE, ROBERT M.
To: PRO-VIRUS, INC.
Reel/Frame 012857/0965 →
Assignment of Assignor's Interest
May 15, 2002
From: OTTAWA, UNIVERSITY OF
To: PRO-VIRUS, INC.
Reel/Frame 012899/0273 →
Re-Record to Correct the Execution Date Previously Recorded at Reel 012669 Frame 0031. (Assignment of Assignor's Interest)
May 15, 2002
From: OTTAWA, UNIVERSITY OF
To: PRO-VIRUS, INC.
Reel/Frame 012904/0890 →
Assignment of Assignor's Interest
Dec 9, 2002
From: LORENCE, ROBERT M.
To: WELLSTAT BIOLOGICS CORPORATION
Reel/Frame 013564/0199 →
Assignment of Assignor's Interest
Apr 25, 2003
From: ROBERTS, MICHAEL S.
To: WELLSTAT BIOLOGICS CORPORATION
Reel/Frame 014017/0257 →
Assignment of Assignor's Interest
Sep 25, 2003
From: LORENCE, ROBERT M.
To: WELLSTAT BIOLOGICS CORPORATION
Reel/Frame 014530/0934 →
Assignment of Assignor's Interest
Nov 3, 2003
From: LORENCE, ROBERT M.
To: WELLSTAT BIOLOGICS CORPORATION
Reel/Frame 014665/0979 →
Assignment of Assignor's Interest
Oct 26, 2004
From: BUASEN, PETE T.; CARDIN, SYLVAIN; LORENCE, ROBERT M.
To: WELLSTAT BIOLOGICS CORPORATION
Reel/Frame 016503/0527 →
Assignment of Assignor's Interest
Oct 12, 2006
From: ATKINS, HAROLD; BELL, JOHN C.; LICHTY, BRIAN D.; STOJDL, DAVID F.
To: UNIVERSITY OF OTTAWA
Reel/Frame 018382/0197 →
Assignment of Assignor's Interest
Oct 12, 2006
From: HEILMAN, CONRAD J., JR.; LORENCE, ROBERT M.; ROBERTS, MICHAEL S.
To: PRO-VIRUS
Reel/Frame 018382/0399 →
Change of Name
Oct 13, 2006
From: PRO-VIRUS
To: WELLSTAT BIOLOGICS CORPORATION
Reel/Frame 018390/0826 →
Change of Name
Aug 7, 2009
From: PRO-VIRUS, INC
To: WELLSTAT BIOLOGICS CORPORATION
Reel/Frame 023069/0479 →